These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 29403264

  • 21. Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands.
    Szczepańska K, Karcz T, Mogilski S, Siwek A, Kuder KJ, Latacz G, Kubacka M, Hagenow S, Lubelska A, Olejarz A, Kotańska M, Sadek B, Stark H, Kieć-Kononowicz K.
    Eur J Med Chem; 2018 May 25; 152():223-234. PubMed ID: 29723785
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of the reproductive and developmental toxicity of the AT1-selective angiotensin II receptor antagonist losartan in rats.
    Spence SG, Cukierski MA, Manson JM, Robertson RT, Eydelloth RS.
    Teratology; 1995 Jun 25; 51(6):383-97. PubMed ID: 7502238
    [Abstract] [Full Text] [Related]

  • 23. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Massa V, Wlodarczyk B, Giavini E, Finnell RH.
    Birth Defects Res A Clin Mol Teratol; 2006 Mar 25; 76(3):200-4. PubMed ID: 16511884
    [Abstract] [Full Text] [Related]

  • 24. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U, Volland J, Nau H.
    Neurotoxicol Teratol; 2008 Mar 25; 30(5):390-4. PubMed ID: 18455366
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the developmental toxicity of aspirin in rabbits when administered throughout organogenesis or during sensitive windows of development.
    Cappon GD, Gupta U, Cook JC, Tassinari MS, Hurtt ME.
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb 25; 68(1):38-46. PubMed ID: 12852482
    [Abstract] [Full Text] [Related]

  • 26. The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice.
    Eissa N, Azimullah S, Jayaprakash P, Jayaraj RL, Reiner D, Ojha SK, Beiram R, Stark H, Łażewska D, Kieć-Kononowicz K, Sadek B.
    Chem Biol Interact; 2019 Oct 01; 312():108775. PubMed ID: 31369746
    [Abstract] [Full Text] [Related]

  • 27. Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H3R ligands.
    Kuder KJ, Łażewska D, Kaleta M, Latacz G, Kottke T, Olejarz A, Karcz T, Fruziński A, Szczepańska K, Karolak-Wojciechowska J, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2017 May 15; 25(10):2701-2712. PubMed ID: 28372935
    [Abstract] [Full Text] [Related]

  • 28. Antiseizure Properties of Histamine H3 Receptor Antagonists Belonging 3,4-Dihydroquinolin-2(1H)-Ones.
    Hua Y, Song M, Guo Q, Luo Y, Deng X, Huang Y.
    Molecules; 2023 Apr 12; 28(8):. PubMed ID: 37110645
    [Abstract] [Full Text] [Related]

  • 29. Effect of clobenpropit, a centrally acting histamine H3-receptor antagonist, on electroshock- and pentylenetetrazol-induced seizures in mice.
    Fischer W, van der Goot H.
    J Neural Transm (Vienna); 1998 Apr 12; 105(6-7):587-99. PubMed ID: 9826104
    [Abstract] [Full Text] [Related]

  • 30. Effects of valproic acid on the placental barrier in the pregnant mouse: Optical imaging and transporter expression studies.
    Meir M, Bishara A, Mann A, Udi S, Portnoy E, Shmuel M, Eyal S.
    Epilepsia; 2016 Jun 12; 57(6):e108-12. PubMed ID: 27142887
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of stereoselective anticonvulsant, teratogenic, and pharmacokinetic profile of valnoctylurea (capuride): a chiral stereoisomer of valproic acid urea derivative.
    Shimshoni JA, Yagen B, Wlodarczyk B, Finnell RH, Schurig V, Bialer M.
    Epilepsia; 2010 Mar 12; 51(3):323-32. PubMed ID: 19674061
    [Abstract] [Full Text] [Related]

  • 32. Anti-epileptic activity, toxicity and teratogenicity in CD1 mice of a novel valproic acid arylamide derivative, N-(2-hydroxyphenyl)-2-propylpentanamide.
    Cristóbal-Luna JM, Correa-Basurto J, Mendoza-Figueroa HL, Chamorro-Cevallos G.
    Toxicol Appl Pharmacol; 2020 Jul 15; 399():115033. PubMed ID: 32387339
    [Abstract] [Full Text] [Related]

  • 33. The Potent and Selective Histamine H3 Receptor Antagonist E169 Counteracts Cognitive Deficits and Mitigates Disturbances in the PI3K/AKT/GSK-3β Signaling Pathway in MK801-Induced Amnesia in Mice.
    Abdalla S, Eissa N, Jayaprakash P, Beiram R, Kuder KJ, Łażewska D, Kieć-Kononowicz K, Sadek B.
    Int J Mol Sci; 2023 Aug 12; 24(16):. PubMed ID: 37628900
    [Abstract] [Full Text] [Related]

  • 34. Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid.
    Baronio D, Castro K, Gonchoroski T, de Melo GM, Nunes GD, Bambini-Junior V, Gottfried C, Riesgo R.
    PLoS One; 2015 Aug 12; 10(1):e0116363. PubMed ID: 25560049
    [Abstract] [Full Text] [Related]

  • 35. Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: a potential for a second generation drug to valproic acid.
    Shimshoni JA, Yagen B, Pessah N, Wlodarczyk B, Finnell RH, Bialer M.
    Epilepsia; 2008 Jul 12; 49(7):1202-12. PubMed ID: 18435754
    [Abstract] [Full Text] [Related]

  • 36. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F, Rohatagi S, Pino M, DeLise B, Zhang J, Nguyen M, Guittin P, Barbellion S, Brunel P, Hofmann T, Schmidt J, Wong M, Lockey P, Lerman S, Clark R.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr 12; 71(2):69-79. PubMed ID: 15098200
    [Abstract] [Full Text] [Related]

  • 37. Characterizing the effects of in utero valproic acid exposure on murine fetoplacental development.
    Shafique S, Winn LM.
    Placenta; 2021 Sep 01; 112():141-152. PubMed ID: 34352490
    [Abstract] [Full Text] [Related]

  • 38. Predicting the human teratogenic potential of the anticonvulsant, valproic acid, from a non-human primate model.
    Mast TJ, Cukierski MA, Nau H, Hendrickx AG.
    Toxicology; 1986 May 01; 39(2):111-9. PubMed ID: 3085290
    [Abstract] [Full Text] [Related]

  • 39. 3-(1'-Cyclobutylspiro[4H-1,3-benzodioxine-2,4'-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonist.
    Hudkins RL, Gruner JA, Raddatz R, Mathiasen JR, Aimone LD, Marino MJ, Bacon ER, Williams M, Ator MA.
    Neuropharmacology; 2016 Jul 01; 106():37-45. PubMed ID: 26400408
    [Abstract] [Full Text] [Related]

  • 40. Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models.
    Gavzan H, Sayyah M, Sardari S, Babapour V.
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct 01; 388(10):1029-38. PubMed ID: 26018398
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.